Clinical trials
Observational Diabetes Mellitus, Type 2 trials in Spain
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
45 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 2 |
| 2008 | 2 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 3 |
| 2015 | 4 |
| 2017 | 3 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 5 |
| 2023 | 4 |
| 2024 | 3 |
| 2025 | 4 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 33 |
| Recruiting | 7 |
| Unknown status | 3 |
| Not yet recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novo Nordisk A/S | 8 |
| Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina | 4 |
| AstraZeneca | 3 |
| Hospital Universitari Vall d'Hebron Research Institute | 3 |
| Bayer | 2 |
| Cardenal Herrera University | 2 |
| Clinica Universidad de Navarra, Universidad de Navarra | 2 |
| Medical University of Graz | 2 |
| Outcomes'10 | 2 |
| Aeterna Medical Solutions SL | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 2 | 45 |
| Diabetes Mellitus | 8 |
| Obesity | 7 |
| Diabetes Mellitus, Type 1 | 5 |
| Renal Insufficiency, Chronic | 4 |
| Liver Cirrhosis | 3 |
| Fatty Liver | 2 |
| Hypertension | 2 |
| Hypoglycemia | 2 |
| Insulin Resistance | 2 |
Trials
Showing 1 to 25 of 45. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.